6,500 Shares in Amrize Ltd $AMRZ Bought by swisspartners Advisors Ltd

swisspartners Advisors Ltd bought a new position in shares of Amrize Ltd (NYSE:AMRZ) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 6,500 shares of the company’s stock, valued at approximately $324,000. Amrize comprises about 0.3% of swisspartners Advisors Ltd’s holdings, making the stock its 21st largest position.

A number of other hedge funds have also bought and sold shares of the company. Covey Capital Advisors LLC bought a new position in Amrize during the second quarter worth $1,176,000. Virtus Family Office LLC bought a new position in Amrize during the second quarter worth $253,000. Teacher Retirement System of Texas bought a new position in Amrize during the second quarter worth $11,149,000. Bessemer Group Inc. bought a new position in Amrize during the second quarter worth $16,489,000. Finally, Wesleyan Assurance Society bought a new position in Amrize during the second quarter worth $2,343,000.

Insider Activity at Amrize

In other Amrize news, insider Mario Gross bought 3,000 shares of the firm’s stock in a transaction dated Wednesday, August 13th. The stock was bought at an average cost of $49.63 per share, with a total value of $148,890.00. Following the completion of the transaction, the insider directly owned 23,232 shares in the company, valued at approximately $1,153,004.16. The trade was a 14.83% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CTO Roald Brouwer bought 2,000 shares of the firm’s stock in a transaction dated Wednesday, August 27th. The shares were acquired at an average cost of $51.88 per share, with a total value of $103,760.00. Following the completion of the transaction, the chief technology officer owned 5,000 shares of the company’s stock, valued at $259,400. This represents a 66.67% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders purchased a total of 1,179,000 shares of company stock valued at $56,120,460 over the last quarter.

Analyst Ratings Changes

Several research firms have weighed in on AMRZ. JPMorgan Chase & Co. lifted their price target on shares of Amrize from $52.00 to $60.00 and gave the company an “overweight” rating in a research note on Tuesday, August 26th. Kepler Capital Markets upgraded shares of Amrize to a “strong-buy” rating in a report on Tuesday, October 21st. Weiss Ratings reiterated a “hold (c)” rating on shares of Amrize in a report on Thursday. Royal Bank Of Canada dropped their price objective on shares of Amrize from $61.00 to $54.00 and set an “outperform” rating on the stock in a report on Friday, August 8th. Finally, Oppenheimer began coverage on Amrize in a report on Tuesday, September 9th. They set an “outperform” rating and a $62.00 price objective for the company. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, Amrize has a consensus rating of “Moderate Buy” and a consensus target price of $58.14.

Amrize Price Performance

NYSE:AMRZ opened at $51.77 on Friday. The company has a current ratio of 1.38, a quick ratio of 0.85 and a debt-to-equity ratio of 0.42. The stock’s 50-day simple moving average is $50.61. The company has a market capitalization of $28.63 billion and a P/E ratio of 66.37. Amrize Ltd has a one year low of $44.12 and a one year high of $56.29.

Amrize (NYSE:AMRZ) last posted its earnings results on Wednesday, August 6th. The company reported $0.78 EPS for the quarter, missing the consensus estimate of $1.03 by ($0.25). The firm had revenue of $3.22 billion for the quarter.

Amrize Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.